Roumeliotis Stefanos, Georgianos Panagiotis I, Roumeliotis Athanasios, Eleftheriadis Theodoros, Stamou Aikaterini, Manolopoulos Vangelis G, Panagoutsos Stylianos, Liakopoulos Vassilios
Division of Nephrology and Hypertension, 1st Department of Internal Medicine, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
Department of Nephrology, School of Medicine, University of Thessaly, 38221 Larissa, Greece.
Life (Basel). 2021 May 29;11(6):504. doi: 10.3390/life11060504.
Proteinuria is characterized by low accuracy for predicting onset and development of diabetic kidney disease (DKD) because it is not directly associated with molecular changes that promote DKD, but is a result of kidney damage. Oxidized low-density lipoprotein (ox-LDL) reflects oxidative stress and endothelial dysfunction, both underlying the development of proteinuria and loss of kidney function in DKD. We aimed to investigate whether ox-LDL modifies the association between proteinuria and progression of DKD in a cohort of 91 patients with proteinuric DKD and diabetic retinopathy, followed for 10 years. The primary endpoint was a combined kidney outcome of eGFR decline ≥30% or progression to end-stage kidney disease. After the end of the study, we considered the percentage change of eGFR over time as our secondary outcome. Proteinuria was associated with both outcomes, and ox-LDL amplified the magnitude of this link ( < 0.0001 for primary and < 0.0001 for secondary outcome, respectively). After adjustment for duration of diabetes, history of cardiovascular disease and serum albumin, ox-LDL remained a significant effect modifier of the association between proteinuria and eGFR decline over time ( = 0.04). Our study shows that in proteinuric DKD, circulating ox-LDL levels amplified the magnitude of the association between proteinuria and progression of DKD.
蛋白尿对于预测糖尿病肾病(DKD)的发病和发展具有较低的准确性,因为它与促进DKD的分子变化没有直接关联,而是肾脏损伤的结果。氧化型低密度脂蛋白(ox-LDL)反映了氧化应激和内皮功能障碍,这两者都是DKD中蛋白尿发生和肾功能丧失的潜在原因。我们旨在调查在91例患有蛋白尿性DKD和糖尿病视网膜病变的患者队列中,随访10年,ox-LDL是否会改变蛋白尿与DKD进展之间的关联。主要终点是估算肾小球滤过率(eGFR)下降≥30%或进展至终末期肾病的联合肾脏结局。在研究结束后,我们将eGFR随时间的百分比变化作为次要结局。蛋白尿与这两个结局均相关,并且ox-LDL放大了这种关联的程度(主要结局<0.0001,次要结局<0.0001)。在调整糖尿病病程、心血管疾病史和血清白蛋白后,ox-LDL仍然是蛋白尿与eGFR随时间下降之间关联的显著效应修饰因素(P = 0.04)。我们的研究表明,在蛋白尿性DKD中,循环ox-LDL水平放大了蛋白尿与DKD进展之间关联的程度。